Document is current

Article History

Accepted: 29 April 2021

First Online: 15 May 2021

Declarations

:

: No funding was received for the preparation of this article.

: Veronique F. Kugener is employed and holds stocks in Takeda Pharmaceuticals International Co. She has no potential conflict of interest related to the content of this article. Eric S. Freedland is employed by Takeda Pharmaceuticals International Co. and has no potential conflict of interest related to the content of this article. Kenneth I. Maynard is employed by Takeda Pharmaceuticals International Co., is a member of the National Advisory Neurological Disorders and Stroke (NANDSC) Council (designated as Special [US] Government Employee), and is a founder/CEO of Career and Corporate Coaching, LLC. He holds stocks and options with AAL, AAPL, ALGN, ALT, AMAT, BIG, BTSC, FAS, FNMA, FSLR, INO, NFLX, NIO, OLED, PDD, PTON, SSO, TSLA, XME, UAL, WFH, ZM, and SAN. Kenneth I. Maynard has no potential conflict of interest related to the content of this article. Omar Aimer is employed by Brunel Canada and has no potential conflict of interest related to the content of this article. Peggy S. Webster is employed by GlaxoSmithKline and holds stocks and options in GlaxoSmithKline. She has no potential conflict of interest related to the content of this article. Maribel Salas is employed by Daiichi Sankyo, Inc. and CCEB/CPeRT, Perelman School of Medicine, University of Pennsylvania and holds stock and options in Daiichi Sankyo, Inc. Maribel Salas has no potential conflict of interest related to the content of this article. Maxine Gossell-Williams is employed by the Section of Pharmacology and Pharmacy, Faculty of Medical Sciences Teaching and Research Complex, University of The West Indies and has no potential conflict of interest related to the content of this article.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: All authors contributed to, edited, and approved the final manuscript.